Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.96 +0.39 (+24.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nautilus Biotechnology (NAUT) Non Operating Investment Income (2020 - 2021)

Updated

Nautilus Biotechnology (NAUT) reported Non Operating Investment Income of $10,982 for Q1 2021.

Analysis

Nautilus Biotechnology (NAUT) Non Operating Investment Income (2020 - 2021) Analysis & Trends

For FY2020, Nautilus Biotechnology posted Non Operating Investment Income of $52,952.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Nautilus Biotechnology 249.36 Mn 249.36 Mn 175,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10,982.00
Sep 30, 2020 15,680.00
API Access

Nautilus Biotechnology Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NAUT&period=max&api_key=YOUR_API_KEY